You are here:

ropinirole tablets (Adartrel)


Following a re-submission.

Ropinirole (Adartrel) is accepted for restricted use within NHS Scotland for the treatment of moderate to severe idiopathic restless legs syndrome (RLS).Its use should be restricted to patients with a baseline score of 24 points or more on the International Restless Legs Scale (IRLS).

Compared with placebo, ropinirole was associated with a 4-point improvement on the 40- point IRLS in a pooled analysis restricted to patients with IRLS score of 24 points.

Drug Details

Drug Name: ropinirole tablets (Adartrel)
SMC Drug ID: 165/05
Manufacturer: GlaxoSmithKline UK Ltd
Indication: Moderate to severe idiopathic restless legs syndrome
BNF Category:
Sub Category: 4.9 Drugs used in Parkinsonism and related disorders
Submission Type: Resubmission
Status: Restricted
Date Advice Published: 10 July 2006